Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (311-320 of 721) with videos related to

Pageof 73
Sort By:
Nuclear Medicine Communications|March 4, 2021
The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapyAkram Al-Ibraheem, Fawzi Abuhijla, Samer Salah, et al.
Nuklearmedizin. Nuclear Medicine|July 29, 2021
[Fireside chat "§ 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital]Marianne Patt, Frank Bengel, Markus Essler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisMaria Papathanasiou, Lukas Kessler, Frank M Bengel, et al.
Nuklearmedizin. Nuclear Medicine|April 3, 2020
Bernd Joachim Krause, Peter Bartenstein, Lutz Stefan Freudenberg, et al.
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physiciansDimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, et al.
BMC Cancer|January 15, 2021
Evaluation of <sup>18</sup>F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Urologia Internationalis|February 3, 2018
Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance ImagingMohammad Al-Bayati, Johannes Grueneisen, Susanne Lütje, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2009
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancersKen Herrmann, Axel Walch, Benjamin Balluff, et al.
Seminars in Nuclear Medicine|July 16, 2024
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyAlexandros Moraitis, Alina Küper, Johannes Tran-Gia, et al.
Pageof 73

Showing results (311-320 of 721) with videos related to

Sort By:
Pageof 73
Nuclear Medicine Communications|March 4, 2021
The influence of 68Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapyAkram Al-Ibraheem, Fawzi Abuhijla, Samer Salah, et al.
Nuklearmedizin. Nuclear Medicine|July 29, 2021
[Fireside chat "§ 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital]Marianne Patt, Frank Bengel, Markus Essler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisMaria Papathanasiou, Lukas Kessler, Frank M Bengel, et al.
Nuklearmedizin. Nuclear Medicine|April 3, 2020
Bernd Joachim Krause, Peter Bartenstein, Lutz Stefan Freudenberg, et al.
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physiciansDimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, et al.
BMC Cancer|January 15, 2021
Evaluation of <sup>18</sup>F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionManuel Weber, Walter Jentzen, Regina Hofferber, et al.
Urologia Internationalis|February 3, 2018
Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance ImagingMohammad Al-Bayati, Johannes Grueneisen, Susanne Lütje, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2009
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancersKen Herrmann, Axel Walch, Benjamin Balluff, et al.
Seminars in Nuclear Medicine|July 16, 2024
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyAlexandros Moraitis, Alina Küper, Johannes Tran-Gia, et al.
Pageof 73